Salt Lake City, UT, United States of America

Daniel Wettstein


Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Daniel Wettstein: Innovator in Cancer Therapeutics

Introduction

Daniel Wettstein is a prominent inventor based in Salt Lake City, Utah, known for his significant contributions to the field of cancer treatment. With a remarkable portfolio of six patents, he has dedicated his career to developing innovative therapeutic compounds that aim to improve patient outcomes in oncology.

Latest Patents

Among Daniel Wettstein's latest inventions are two notable patents focusing on purine-core inhibitors of HSP90, which are crucial in cancer treatment. The first patent outlines compounds of specific formulae with various substituents, targeting therapeutic applications. These compounds involve aryl, heteroaryl, and carbocyclic groups, aimed at inhibiting HSP90 and providing new avenues in cancer therapy. The second patent elaborates on similar compounds and their therapeutic potential, emphasizing the significant role of specific substituents in the development of effective cancer treatments.

Career Highlights

Throughout his career, Daniel Wettstein has worked with leading biotechnology firms, including Myriad Genetics, Inc. and Myriad Pharmaceuticals, Inc. His tenure at these organizations has positioned him at the forefront of research and development in cancer therapeutics, allowing him to translate scientific discoveries into real-world applications. His numerous patents reflect not only his innovative mindset but also his commitment to advancing medical science.

Collaborations

Daniel Wettstein has collaborated with esteemed colleagues in the field, including Ashok Bajji and Se-Ho Kim. These partnerships have played a crucial role in the successful development and commercialization of his patented inventions, fostering a collaborative environment that encourages innovation and scientific inquiry.

Conclusion

In summary, Daniel Wettstein exemplifies the spirit of innovation in the realm of cancer therapeutics. With his six patents and a background rich in collaboration and industry experience, he continues to contribute valuable advancements that hold the potential to transform the treatment landscape for cancer patients. His work reflects a dedication to improving health outcomes and illustrates the importance of inventive thinking in addressing complex medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…